You can meet and interact with AKESOgen at the following events.


AKESOgen supports College of American Pathologists (CAP) Program in Sao Paulo, Brazil

Dr. Bouzyk was invited by the College of American Pathologists to be on the faculty and a speaker for this International Education Program where participants came from various laboratories in South America including Brazil and Argentina.

Dr. Mark Bouzyk CAP Brazil

Pictured with Dr. Mark Bouzyk (Left to Right): Dr. Leonas Bekeris (CAP Regional Commissioner, South America and Mexico), Denise Driscoll (Senior Director, Accreditation & Regulatory Affairs, CAP), Dr. Bharati Jhaveri (Governor, College of American Pathologists, Chair Council on Accreditation, International Deputy Regional Commissioner), Dr. Mark Bouzyk (CSO, AKESOgen) – the CAP faculty for the event – and Dr. Edgar Gil Rizzatti (Medical and Technical Executive Director (GrupoFleury, Brazil) – who hosted the event.

Dr. Mark Bouzyk CAP Brazil

Another picture shows Dr. Bouzyk and the faculty with some of the participants.

Dr. Mark Bouzyk CAP Brazil

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen delegates attend and present at ASHG in Vancouver


AKESOgen exhibited and presented at the American Society of Human Genetics 2016 Annual Meeting in Vancouver, Canada, October 18th – 22nd.

Dr. Bouzyk presented novel genotyping solutions for large scale genotyping studies. We invite you learn more about our genomics solutions in:

  • Research Services
  • Clinical Diagnostics Services
  • Clinical Trials Services

by contacting us at 770 542 0890 or emailing


Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail
cancer research Wales

Dr. Mark Bouzyk to Keynote at the 50th anniversary of Cancer Research Wales, Ymchwil Canser Cymru

March 1st, 2016 – Dr. Mark Bouzyk, CSO of AKESOgen, has been invited to the SWALEC stadium in Cardiff, U.K for the Cancer Research Wales 50th anniversary.   March 1st commemorates St. David’s day, a national day of celebration within Wales. Cancer Research Wales will be showcasing its milestones and research achievements over the last 50 years with the theme of the symposium is “Cancer Research Wales at 50 Working Towards Precision Medicine.”  The symposium will bring together top cancer scientists and clinicians from across Wales and the UK giving them an opportunity to discuss and share their latest findings but also plan future collaborations.


Cancer Research WalesAKESOgen-Logo333

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail
ASHG Logo-2015


AKESOgen scientists attended ASHG in Baltimore, MD, October 7-
9, 2015. Please email or call 770 542 0890 to discuss your genomics needs.

HighResLog-oldMark_at_ASHG15ASHG Logo-2015

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500


AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500

AKESOgen Ranks as the No. 44 Healthcare Company and 363rd Overall on the 2015 Inc.500 with Three-Year Sales Growth of 1,300%

NEW YORK and ATLANTA, August 12, 2015Inc. magazine today ranked the genomics services provider, AKESOgen, 44th as a Healthcare company and 363rd overall on its 34th annual Inc.500|5000, an exclusive ranking of the nation’s fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent entrepreneurs. Companies such as Intuit, Zappos, Under Armour, Microsoft, GoPro, Timberland, Clif Bar, Patagonia, Oracle, and many other well-known names gained early exposure as members of the Inc.500|5000.

“We are delighted to be recognized as an Inc.500 honoree with such well known organizations in 2015 as Fitbit, Smashburger, Bowlmor AMF, Planet Fitness,, Radio Flyer, Box, and Mindbody.” commented AKESOgen CEO Robert Boisjoli.

“Genetics and Precision Medicine are becoming more and more pervasive in our society. As a result, there is an unprecedented need for genomics capabilities in clinical trials and diagnostics, in addition to research. AKESOgen is at the forefront of providing these molecular technologies for 21st century personalized medicine.” says Mark Bouzyk, AKESOgen’s CSO.

This year’s crop of Inc.500 companies is the most competitive in the list’s history. “For 34 years, Inc. has welcomed the fastest-growing companies in America into a very exclusive club. To make it among the top 500 companies on the list, honorees had to have grown at least tenfold over the past three years. That’s a result most businesses could only dream of…” says Inc. President and Editor-In-Chief Eric Schurenberg.

Complete results of the Inc.500|5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at

About Inc. Magazine

Founded in 1979 and acquired in 2005 by Mansueto VenturesInc. Magazine is the only major brand dedicated exclusively to owners and managers of growing private companies.  Total monthly audience reach for the brand has reached over 6,000,000 in 2015.  For more information, visit

About AKESOgen, Inc.

AKESOgen is an integrated genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta USA, the company’s main focus is oncology and personalized medicine. AKESOgen’s services include providing high-throughput, biomarker profiling, cytogenetic arrays, sequencing, and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. For more information, visit

Media Contact:

Crystal Yang, Client Relations Specialist, Scientific Affairs, AKESOgen, Inc. +1 770-542-0890 ext 101 (office), or

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

CSO of AKESOgen to speak at and attend the Third International Conference on Biomarkers Discovery and Clinical Application.

AKESOgen scientists to attend the third ICB conference in Shanghai, China from October 17-18, 2015.  AKESOgen’s CSO, Mark Bouzyk, has been invited to speak as a leading expert on genomic profiling in multiple cancers, specifically towards Precision Medicine.

ICB logo-Shanghai           AKESOgen-Logo333

Please email or call 770 542 0890 if you want to schedule an appointment with a delegate or to discuss your genomics needs.

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail